These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38296815)

  • 1. Emerging drugs for the treatment of irritability associated with autism spectrum disorder.
    Shamabadi A; Karimi H; Arabzadeh Bahri R; Motavaselian M; Akhondzadeh S
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):45-56. PubMed ID: 38296815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pharmacotherapy for the treatment of cannabis use disorder.
    Shamabadi A; Arabzadeh Bahri R; Karimi H; Heidari E; Akhondzadeh S
    Expert Opin Pharmacother; 2024 Apr; 25(6):695-703. PubMed ID: 38717605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole for treating irritability associated with autism spectrum disorders.
    Bartram LA; Lozano J; Coury DL
    Expert Opin Pharmacother; 2019 Aug; 20(12):1421-1427. PubMed ID: 31180743
    [No Abstract]   [Full Text] [Related]  

  • 10. Aripiprazole for the treatment of irritability associated with autism.
    Farmer CA; Aman MG
    Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotics for behavioral problems in children.
    Shafiq S; Pringsheim T
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
    Lamberti M; Siracusano R; Italiano D; Alosi N; Cucinotta F; Di Rosa G; Germanò E; Spina E; Gagliano A
    Paediatr Drugs; 2016 Aug; 18(4):319-29. PubMed ID: 27278054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment.
    Choi H; Kim JH; Yang HS; Kim JY; Cortese S; Smith L; Koyanagi A; Dragioti E; Radua J; Fusar-Poli P; Shin JI; Cheon KA; Solmi M
    Mol Autism; 2024 Jan; 15(1):7. PubMed ID: 38263251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA
    Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
    Salazar de Pablo G; Pastor Jordá C; Vaquerizo-Serrano J; Moreno C; Cabras A; Arango C; Hernández P; Veenstra-VanderWeele J; Simonoff E; Fusar-Poli P; Santosh P; Cortese S; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2023 Feb; 62(2):151-168. PubMed ID: 35470032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Hellings JA; Arnold LE; Han JC
    Expert Opin Pharmacother; 2017 Apr; 18(6):581-588. PubMed ID: 28335658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on pharmacotherapy of autism spectrum disorder in children and adolescents.
    Goel R; Hong JS; Findling RL; Ji NY
    Int Rev Psychiatry; 2018 Feb; 30(1):78-95. PubMed ID: 29693461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
    Arteaga-Henríquez G; Gisbert L; Ramos-Quiroga JA
    CNS Drugs; 2023 Mar; 37(3):215-229. PubMed ID: 36913130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.